December deadline nears for applying for position on EU pharmacovigilance PRAC committee
This article was originally published in SRA
The 1 December deadline is nearing for interested parties to inform the European Commission that they are interested in becoming a member of the Pharmacovigilance Risk Assessment Committee that the European Medicines Agency is required to set up in July 20121,2.
You may also be interested in...
The European Medicines Agency has agreed to review pan-EU marketing applications for a number of new medicines.
Only two of seven recent applications for entry into the European Medicines Agency’s priority medicines scheme for getting treatments for unmet medical needs to patients faster made the grade.
The first chemotherapy-free, first-line treatment for chronic lymphocytic leukemia where dosing can be completed in one year has received the thumbs up by the European Medicines Agency.